000 01375 a2200373 4500
005 20250514212817.0
264 0 _c20050408
008 200504s 0 0 eng d
022 _a1537-1891
024 7 _a10.1016/j.vph.2004.08.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCastillo-Hernandez, Jesus R
245 0 0 _aIntracoronary angiotensin II causes inotropic and vascular effects via different paracrine mechanisms.
_h[electronic resource]
260 _bVascular pharmacology
_c
300 _a147-58 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiotensin II
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aCardiotonic Agents
_xadministration & dosage
650 0 4 _aCoronary Vessels
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMyocardial Contraction
_xdrug effects
650 0 4 _aParacrine Communication
_xdrug effects
650 0 4 _aRats
700 1 _aRubio-Gayosso, Ivan
700 1 _aSada-Ovalle, Isabel
700 1 _aGarcia-Vazquez, Alicia
700 1 _aCeballos, Guillermo
700 1 _aRubio, Rafael
773 0 _tVascular pharmacology
_gvol. 41
_gno. 4-5
_gp. 147-58
856 4 0 _uhttps://doi.org/10.1016/j.vph.2004.08.002
_zAvailable from publisher's website
999 _c15289484
_d15289484